Cargando…
Exploring pta Alternatives in the Development of Ruthenium–Arene Anticancer Compounds
Organoruthenium pyrithione (1-hydroxypyridine-2-thione) complexes have been shown in our recent studies to be a promising family of compounds for development of new anticancer drugs. The complex [(η(6)-p-cymene)Ru(pyrithionato)(pta)]PF(6) contains phosphine ligand pta (1,3,5-triaza-7-phosphaadamanta...
Autores principales: | Kljun, Jakob, Rebernik, Mihaela, Balsa, Lucía M., Kladnik, Jerneja, Rapuš, Uroš, Trobec, Tomaž, Sepčić, Kristina, Frangež, Robert, León, Ignacio E., Turel, Iztok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058425/ https://www.ncbi.nlm.nih.gov/pubmed/36985471 http://dx.doi.org/10.3390/molecules28062499 |
Ejemplares similares
-
Novel Organoruthenium(II) Complex C1 Selectively Inhibits Butyrylcholinesterase without Side Effects on Neuromuscular Transmission
por: Trobec, Tomaž, et al.
Publicado: (2023) -
Fine Tuning of Cholinesterase and Glutathione-S-Transferase Activities by Organoruthenium(II) Complexes
por: Trobec, Tomaž, et al.
Publicado: (2021) -
Structural Isomerism and Enhanced Lipophilicity of Pyrithione Ligands of Organoruthenium(II) Complexes Increase Inhibition on AChE and BuChE
por: Kladnik, Jerneja, et al.
Publicado: (2020) -
Comparison of Solution Chemical Properties and Biological Activity of Ruthenium Complexes of Selected β-Diketone, 8-Hydroxyquinoline and Pyrithione Ligands
por: Pivarcsik, Tamás, et al.
Publicado: (2021) -
Binding Kinetics of Ruthenium Pyrithione Chemotherapeutic Candidates to Human Serum Proteins Studied by HPLC-ICP-MS
por: Marković, Katarina, et al.
Publicado: (2020)